Figure 1.
Figure 1. Mouse models: key milestones and timeline. A schematic of publication dates and the disease phenotype for different model systems. Green, expression from the endogenous locus; red, viral transduction models; blue, stable transgene models. MLL-AF9 models: 1996,26 2000,30 2005,322006,33,34 2007,402008,412013,362015,42 2016.38 MLL-ENL models: 1997,43 2003,31,35,45 2005,32 2007,40 2009,11 2012,48 2014,502015.42 MLL-AF4 models: 2006,27,52 2008,54 2010,8 2011,56,60 2016.65 OHT, 4-hydroxytamoxifen; Ras, rat sarcoma mutation; t-ALL, T-cell acute lymphoblastic leukemia.

Mouse models: key milestones and timeline. A schematic of publication dates and the disease phenotype for different model systems. Green, expression from the endogenous locus; red, viral transduction models; blue, stable transgene models. MLL-AF9 models: 1996,26  2000,30  2005,32 2006,33,34  2007,40 2008,41 2013,36 2015,42  2016.38  MLL-ENL models: 1997,43  2003,31,35,45  2005,32  2007,40  2009,11  2012,48  2014,50 2015.42  MLL-AF4 models: 2006,27,52  2008,54  2010, 2011,56,60  2016.65  OHT, 4-hydroxytamoxifen; Ras, rat sarcoma mutation; t-ALL, T-cell acute lymphoblastic leukemia.

Close Modal

or Create an Account

Close Modal
Close Modal